| __timestamp | Protagonist Therapeutics, Inc. | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 7459000 | 11768000 |
| Thursday, January 1, 2015 | 11831000 | 15152000 |
| Friday, January 1, 2016 | 25705000 | 19828000 |
| Sunday, January 1, 2017 | 46181000 | 25573000 |
| Monday, January 1, 2018 | 59497000 | 23634000 |
| Tuesday, January 1, 2019 | 65003000 | 38845000 |
| Wednesday, January 1, 2020 | 74506000 | 50523000 |
| Friday, January 1, 2021 | 126006000 | 75463000 |
| Saturday, January 1, 2022 | 126215000 | 105767000 |
| Sunday, January 1, 2023 | 120161000 | 167512000 |
Unlocking the unknown
In the dynamic world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Xenon Pharmaceuticals Inc. and Protagonist Therapeutics, Inc. have demonstrated significant growth in their R&D budgets, reflecting their dedication to advancing medical science.
From 2014 to 2023, Protagonist Therapeutics increased its R&D expenses by over 1,500%, peaking in 2022 with a 1.26x increase compared to 2021. Meanwhile, Xenon Pharmaceuticals saw a remarkable 1,300% rise, culminating in 2023 with a 58% jump from the previous year. This trend underscores the fierce competition and rapid advancements in the biotech sector.
As these companies continue to push the boundaries of innovation, their escalating R&D investments highlight the relentless pursuit of groundbreaking therapies that could redefine healthcare.
Research and Development Investment: Johnson & Johnson vs Xenon Pharmaceuticals Inc.
Analyzing R&D Budgets: Sanofi vs Xenon Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for Biogen Inc. and Protagonist Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Intra-Cellular Therapies, Inc. and Xenon Pharmaceuticals Inc.
Comparing Innovation Spending: Ascendis Pharma A/S and Protagonist Therapeutics, Inc.
R&D Insights: How Blueprint Medicines Corporation and Xenon Pharmaceuticals Inc. Allocate Funds
Grifols, S.A. vs Protagonist Therapeutics, Inc.: Strategic Focus on R&D Spending
Alkermes plc vs Xenon Pharmaceuticals Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Xenon Pharmaceuticals Inc. and ACADIA Pharmaceuticals Inc.
Research and Development: Comparing Key Metrics for Xenon Pharmaceuticals Inc. and Mesoblast Limited
Who Prioritizes Innovation? R&D Spending Compared for Xenon Pharmaceuticals Inc. and Galapagos NV